Paul N Pfeiffer1, Dara Ganoczy, Mark Ilgen, Kara Zivin, Marcia Valenstein. 1. Department of Veterans Affairs, Health Services Research and Development (HSR&D) Center of Excellence, Serious Mental Illness Treatment Research and Evaluation Center (SMITREC), Ann Arbor, Michigan, USA. ppfeiffe@umich.edu
Abstract
BACKGROUND: Depressive disorders greatly increase suicide risk; however, little is known about the contribution of comorbid anxiety disorders or anxiety symptoms to the risk of suicide death among depressed patients. We examined whether depressed veterans with comorbid anxiety had higher risks of suicide death. METHODS: Using VA administrative databases we identified 887,859 patients with depression. We then used univariate and multivariate logistic regression, controlling for demographics and substance use disorders, to determine the odds ratios of completed suicide associated with individual comorbid anxiety disorders, the presence of any comorbid anxiety disorder, the prescription of an antianxiety medication, or the prescription of a high dose of an antianxiety medication. RESULTS: In multivariate analyses, the odds of completed suicide were significantly increased for patients with panic disorder (OR 1.26, 95% CI: 1.04-1.53), generalized anxiety disorder (OR 1.27, 95% CI: 1.09-1.47), and anxiety disorder, not otherwise specified (OR 1.25, 95% CI: 1.12-1.38). The odds of completed suicide were also greater among patients who received any antianxiety medication (OR 1.71, 95% CI: 1.55-1.88), and were further increased among those who received high dose treatment (OR 2.26, 95% CI: 1.98-2.57). Odds of completed suicide were decreased among patients with comorbid posttraumatic stress disorder (OR 0.87, 95% CI: 0.77-0.97), and there was no statistically significant relationship between social phobia, obsessive-compulsive disorder, and all other anxiety disorders and suicide. CONCLUSIONS: These findings emphasize the importance of comorbid anxiety disorders and symptoms in increasing suicide risk among depressed patients and may inform suicide prevention efforts among these patients. (c) 2009 Wiley-Liss, Inc.
BACKGROUND:Depressive disorders greatly increase suicide risk; however, little is known about the contribution of comorbid anxiety disorders or anxiety symptoms to the risk of suicide death among depressedpatients. We examined whether depressed veterans with comorbid anxiety had higher risks of suicide death. METHODS: Using VA administrative databases we identified 887,859 patients with depression. We then used univariate and multivariate logistic regression, controlling for demographics and substance use disorders, to determine the odds ratios of completed suicide associated with individual comorbid anxiety disorders, the presence of any comorbid anxiety disorder, the prescription of an antianxiety medication, or the prescription of a high dose of an antianxiety medication. RESULTS: In multivariate analyses, the odds of completed suicide were significantly increased for patients with panic disorder (OR 1.26, 95% CI: 1.04-1.53), generalized anxiety disorder (OR 1.27, 95% CI: 1.09-1.47), and anxiety disorder, not otherwise specified (OR 1.25, 95% CI: 1.12-1.38). The odds of completed suicide were also greater among patients who received any antianxiety medication (OR 1.71, 95% CI: 1.55-1.88), and were further increased among those who received high dose treatment (OR 2.26, 95% CI: 1.98-2.57). Odds of completed suicide were decreased among patients with comorbid posttraumatic stress disorder (OR 0.87, 95% CI: 0.77-0.97), and there was no statistically significant relationship between social phobia, obsessive-compulsive disorder, and all other anxiety disorders and suicide. CONCLUSIONS: These findings emphasize the importance of comorbid anxiety disorders and symptoms in increasing suicide risk among depressedpatients and may inform suicide prevention efforts among these patients. (c) 2009 Wiley-Liss, Inc.
Authors: Maria A Oquendo; Masoud Kamali; Steven P Ellis; Michael F Grunebaum; Kevin M Malone; Beth S Brodsky; Harold A Sackeim; J John Mann Journal: Am J Psychiatry Date: 2002-10 Impact factor: 18.112
Authors: T Petteri Sokero; Tarja K Melartin; Heikki J Rytsälä; Ulla S Leskelä; Paula S Lestelä-Mielonen; Erkki T Isometsä Journal: J Clin Psychiatry Date: 2003-09 Impact factor: 4.384
Authors: Lisa S Seyfried; Helen C Kales; Rosalinda V Ignacio; Yeates Conwell; Marcia Valenstein Journal: Alzheimers Dement Date: 2011-11 Impact factor: 21.566
Authors: Marcia Valenstein; Hyungjin Myra Kim; Dara Ganoczy; Daniel Eisenberg; Paul N Pfeiffer; Karen Downing; Katherine Hoggatt; Mark Ilgen; Karen L Austin; Kara Zivin; Frederic C Blow; John F McCarthy Journal: J Clin Psychopharmacol Date: 2012-06 Impact factor: 3.153
Authors: John F McCarthy; Robert M Bossarte; Ira R Katz; Caitlin Thompson; Janet Kemp; Claire M Hannemann; Christopher Nielson; Michael Schoenbaum Journal: Am J Public Health Date: 2015-06-11 Impact factor: 9.308
Authors: Ranran Li; Renrong Wu; Jun Chen; David E Kemp; Ming Ren; Carla Conroy; Philip Chan; Mary Beth Serrano; Stephen J Ganocy; Joseph R Calabrese; Keming Gao Journal: Psychopharmacol Bull Date: 2016-03-01
Authors: Jonathan S Comer; Kaitlin P Gallo; Priya Korathu-Larson; Donna B Pincus; Timothy A Brown Journal: Depress Anxiety Date: 2012-07-16 Impact factor: 6.505